1. Home
  2. BGLC vs PRSO Comparison

BGLC vs PRSO Comparison

Compare BGLC & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • PRSO
  • Stock Information
  • Founded
  • BGLC 2017
  • PRSO 2008
  • Country
  • BGLC Malaysia
  • PRSO United States
  • Employees
  • BGLC N/A
  • PRSO N/A
  • Industry
  • BGLC Medical Specialities
  • PRSO Semiconductors
  • Sector
  • BGLC Health Care
  • PRSO Technology
  • Exchange
  • BGLC Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • BGLC 5.0M
  • PRSO 4.3M
  • IPO Year
  • BGLC N/A
  • PRSO 2001
  • Fundamental
  • Price
  • BGLC $2.71
  • PRSO $1.09
  • Analyst Decision
  • BGLC
  • PRSO Strong Buy
  • Analyst Count
  • BGLC 0
  • PRSO 1
  • Target Price
  • BGLC N/A
  • PRSO $3.00
  • AVG Volume (30 Days)
  • BGLC 69.9K
  • PRSO 455.9K
  • Earning Date
  • BGLC 08-13-2025
  • PRSO 08-11-2025
  • Dividend Yield
  • BGLC N/A
  • PRSO N/A
  • EPS Growth
  • BGLC N/A
  • PRSO N/A
  • EPS
  • BGLC N/A
  • PRSO N/A
  • Revenue
  • BGLC $9,265,870.00
  • PRSO $15,626,000.00
  • Revenue This Year
  • BGLC N/A
  • PRSO $3.96
  • Revenue Next Year
  • BGLC N/A
  • PRSO $36.80
  • P/E Ratio
  • BGLC N/A
  • PRSO N/A
  • Revenue Growth
  • BGLC N/A
  • PRSO 35.50
  • 52 Week Low
  • BGLC $2.01
  • PRSO $0.52
  • 52 Week High
  • BGLC $8.40
  • PRSO $2.34
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 43.64
  • PRSO 56.63
  • Support Level
  • BGLC $2.60
  • PRSO $1.03
  • Resistance Level
  • BGLC $3.06
  • PRSO $1.31
  • Average True Range (ATR)
  • BGLC 0.21
  • PRSO 0.15
  • MACD
  • BGLC -0.06
  • PRSO -0.02
  • Stochastic Oscillator
  • BGLC 16.27
  • PRSO 33.33

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: